Steve Little wins recognition as Young Investigator of 2018
Qrono co-founder Prof. Steven Little was named Young Investigator of 2018 by Controlled Release Society. This award acknowledges his advances in long acting formulation design and development, which have been commercialized by Qrono Inc.
The Pittsburgh Business Times has selected Qrono Inc. for its first annual Innovation Award based on the company’s potential to impact the healthcare industry. This award recognizes Qrono for challenging conventional thinking with its new cancer therapies.
National Cancer Institute funds IND studies for QR206
The National Cancer Institute, part of the National Institutes of Health, has awarded Qrono Inc. a $1.5M small business innovation research contract to advance lead product candidate QR206 through Investigational New Drug studies.